Charlotte Pawlyn
An expert in the field of multiple myeloma with affiliations to The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.
Best podcasts with Charlotte Pawlyn
Ranked by the Snipd community
Oct 13, 2022 • 17min
Highlights from IMS 2022: managing high-risk & frail patients with myeloma and the prognostic value of MRD
Expert guest Charlotte Pawlyn discusses managing high-risk and frail patients with myeloma, including treatment strategies and the importance of standardized definitions. They also highlight the prognostic value of measurable residual disease (MRD) and its application in clinical practice. The recent approval of teclistamab by the European Medicines Agency is also discussed.
